文献速递创伤骨科骨质疏松与代谢性骨病

血清非酯化脂肪酸水平与髋部骨折风险:心血管健康研究

Serum non-esterified fatty acid levels and hip fracture risk: The Cardiovascular Health Study.
PubMed 文献 · Osteoporos Int · 2021-03-02

在心血管健康研究(n=2139,平均年龄77.8岁)的无已知糖尿病老年参与者中,随访11.1年记录到303例新发髋部骨折。多变量Cox模型显示,总反式非酯化脂肪酸水平每升高一个标准差,髋部骨折风险显著升高(HR 1.17,95%CI 1.04–1.31,p=0.01),其他脂肪酸类别与髋部骨折风险无显著关联。

要点

  • 总反式非酯化脂肪酸每升高1个标准差,髋部骨折风险升高(HR 1.17)。
  • SFA二十四烷酸(24:0)与髋部骨折风险升高相关(HR 1.09)。
  • 二十二烷酸(22:0)与二十二碳四烯酸(22:4 n6)与髋部骨折风险降低相关,需其他队列验证。

核心结论

  • 总血浆反式非酯化脂肪酸水平与髋部骨折风险相关,提示从食物中系统性去除反式脂肪酸可能存在尚未被认识到的获益。
  • 单个非酯化脂肪酸与髋部骨折风险的新关联需在其他队列研究中确认。

研究设计与样本

  • 心血管健康研究(Cardiovascular Health Study)参与者的前瞻性队列分析。
  • 采用Cox比例风险模型评估非酯化脂肪酸水平与髋部骨折风险的多变量关联。

主要发现

  • 随访11.1年共记录303例新发髋部骨折。
  • 总反式脂肪酸水平每升高1个标准差,髋部骨折风险升高(HR 1.17,95%CI 1.04–1.31,p=0.01)。
  • SFA二十四烷酸(24:0)与更高风险相关(HR 1.09,95%CI 1.04–1.1,p<0.001)。
  • 二十二烷酸(22:0)与更低风险相关(HR 0.76,95%CI 0.61–0.94,p=0.01)。
  • 二十二碳四烯酸(22:4 n6)与更低风险相关(HR 0.84,95%CI 0.70–1.00,p=0.05)。

关键数值与推荐

  • 总反式非酯化脂肪酸:每1个标准差HR 1.17(95%CI 1.04–1.31,p=0.01)。
  • SFA二十四烷酸(24:0):HR 1.09(95%CI 1.04–1.1,p<0.001)。
  • 二十二烷酸(22:0):HR 0.76(95%CI 0.61–0.94,p=0.01)。
  • 二十二碳四烯酸(22:4 n6):HR 0.84(95%CI 0.70–1.00,p=0.05)。

临床怎么用

  • 对老年人群评估髋部骨折风险时,可将血清总反式非酯化脂肪酸水平作为潜在的代谢参考指标。
  • 反式脂肪酸与髋部骨折风险的关联提示减少膳食反式脂肪酸摄入可能对骨骼健康有益,但需进一步研究验证。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Among elderly participants from the Cardiovascular Health Study, we found that non-esterified trans fatty acid levels had a significant prospective association with hip fracture risk. Other non-esterified fatty acid classes were not associated with hip fracture risk. INTRODUCTION: Serum non-esterified fatty acids (NEFAs) are bioactive metabolic intermediates that can be taken up by bone tissue. Their associations with hip fracture risk have not been previously examined. METHODS: Thirty-five individual NEFAs in five classes (saturated [SFA], mono-un-saturated [MUFA], poly-unsaturated n-6 and n-3 [PUFA], and trans-FA) were measured in Cardiovascular Health Study participants (n = 2139, mean age 77.8 years) without known diabetes. The multivariable associations of NEFA levels with hip fracture risk were evaluated in Cox hazards models. RESULTS: We documented 303 incident hip fractures during 11.1 years of follow-up. Among the five NEFA classes, total trans FA levels were positively associated with higher hip fracture risk (HR 1.17 [95% CI, 1.04, 1.31; p = 0.01] per one standard deviation higher level). The SFA lignoceric acid (24:0) was positively associated with higher risk (HR 1.09 [1.04, 1.1]; p < 0.001), while behenic (22:0) and docosatetraenoic (22:4 n6) acids were associated with lower risk (HR 0.76 [0.61, 0.94]; p = 0.01; 0.84 [0.70, 1.00]; p = 0.05, respectively). CONCLUSION: Total plasma trans NEFA levels are related to hip fracture risk, suggesting an unrecognized benefit of their systematic removal from food. Novel associations of individual NEFAs with hip fracture risk require confirmation in other cohort studies.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Barzilay JI, Buzkova P, Djoussé L, et al. Serum non-esterified fatty acid levels and hip fracture risk: The Cardiovascular Health Study. Osteoporos Int. 2021. PMID: 33651122. doi:10.1007/s00198-021-05897-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。